About US
Contact us
-
Myriad Genetics expands research collaborations with AbbVie, Tesaro and MerckMyriad Genetics has expanded collaboration with AbbVie to accelerate development of the latter's investigational PARP inhibitor, veliparib. The companion diagnostics (CDx) research collaboration buil2016/2/26
-
Bayer sees new med Kovaltry as just one piece of its hemophilia puzzleEarlier this week,Bayernabbed an EU approval for a new, longer-lasting hemophilia med, Kovaltry. But the company isn't expecting all of the patients on stalwart treatment Kogenate to jump ship for the2016/2/25
-
Sanofi cans Auvi-Q marketing deal, putting injector pen's future in limboSanofi ($SNY) is in the process of cleaning house--and its anaphylaxis remedy, Auvi-Q, is next on the list of things to go. As PDL BioPharma ($PDLI) CEO John McLaughlin said earlier this week on his2016/2/25
-
Pfizer workers, retirees face big tax bills from $160B Allergan dealBig-time Pfizer ($PFE) investors are no doubt prepared for the tax hit from its forthcoming merger with Allergan ($ACT). But smaller shareholders, including current and retired employees, could face t2016/2/24
-
Prosecutors raid Novartis South Korea in kickbacks probeNovartis ($NVS) is facing another regulatory pickle in Asia. After a Japanese data scandal forced the company's unit there into temporary suspension last year, South Korean prosecutors have targeted t2016/2/24
-
US FDA grants breakthrough status for Novartis' PKC412 to treat FLT3-mutated AMLThe US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Novartis' investigational drug, PKC412 (midostaurin), to treat FLT3-mutated acute myeloid leukaemia (AML) in2016/2/23
-
Study shows experimental T-cell therapy puts cancer patients in remissionA study conducted by researchers at the Fred Hutchinson Cancer Research Centre has showed that the experimental, living T-cell therapy has put patients with cancer in remission. Patients with acute l2016/2/23
-
AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in salesAstraZeneca ($AZN) snagged EU approval for its gout drug Zurampic, a few months after the med got an FDA green light. The regulatory blessing helps the U.K. drugmaker as it looks to new meds to fill t2016/2/22
-
Pfizer whistleblowers set to collect $59M in Medicaid fraud suitHow much does it pay to sue Big Pharma? In the case of one serial whistleblower, $59 million. Louisiana doctor William LaCorte is set to collect a boatload of cash after filing a whistleblower suit ag2016/2/22
-
WHO recommends control measures to tackle Zika virusThe World Health Organisation (WHO) has announced that the countries battling the Zika virus must implement new tools to prevent it from spreading. The virus is mainly linked to severe birth defects2016/2/19